Asset Details
Do you wish to reserve the book?
Improvement of Semen Parameters in a Man With Idiopathic Severe Oligoasthenoteratozoospermia Using Date Palm Pollen (Phoenix dactylifera L.) Based on Iranian Traditional Medicine: A Case Report
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Improvement of Semen Parameters in a Man With Idiopathic Severe Oligoasthenoteratozoospermia Using Date Palm Pollen (Phoenix dactylifera L.) Based on Iranian Traditional Medicine: A Case Report
Do you wish to request the book?
Improvement of Semen Parameters in a Man With Idiopathic Severe Oligoasthenoteratozoospermia Using Date Palm Pollen (Phoenix dactylifera L.) Based on Iranian Traditional Medicine: A Case Report
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Improvement of Semen Parameters in a Man With Idiopathic Severe Oligoasthenoteratozoospermia Using Date Palm Pollen (Phoenix dactylifera L.) Based on Iranian Traditional Medicine: A Case Report
2018
Overview
Introduction: Almost 50% of infertilities are associated with males and among them 30to 50% are idiopathic. Empirical treatments are used in idiopathic male infertility, yet not enough scientific evidence is available for the application of such remedies. date palm pollen (DPP) is one of the drugs suggested for such patients in Iranian traditional medicine (ITM). Case Presentation: This study was performed on a 35-year-old male patient with idiopathic infertility. He previously had severe oligoasthenoteratozoospermia and was under medical supervision at Yas hospital of the Tehran University of Medical Sciences from August 2016 to February 2017, where he was treated with DPP at a dose of 3 g twice daily, for three months. The second semen analysis was carried out after a quarter of the treatment period, followed by re-analyses after one and three months of finalizing the treatment period. The results obtained showed impressive improvement in the quality of semen parameters. Within six months, the initial values of normal morphology (1%), total motility (3%), progressive motility (0.0), and sperm concentration (0.1 million) increased to 20%, 60%, 10%, and 10 million, respectively. Conclusions: The results of this study indicate that the drug may be operative in improving semen parameters in such patients, and more clinical studies are required in this regard.
